Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: Quinone oxidoreductase polymorphism

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 2, 1997, Pages 87-92

  Wiencke, John K ^a   Spitz, Margaret R ^b   McMillan, Alex ^c   Kelsey, Karl T ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOREDUCTASE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ARTICLE; CANCER RISK; ETHNIC GROUP; GENETIC POLYMORPHISM; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MEXICAN AMERICANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NAD(P)H DEHYDROGENASE (QUINONE); POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0031015975     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Couiltas, D. B., Gong, H. Jr., Grad, R., Handler, A., McCurdy, S. A., Player, R., Rhoades, E. R., Samet, J. M., Thomas, A., and Westley, M. State of the art: respiratory diseases in minorities of the United States. Am. J. Respir. Crit. Care Med., 149: 93-131, 1994.
2. Wiggins, C. L., Becker, T. M., Key, C. R., and Samet, J. M. Cancer mortality among New Mexico's Hispanics, American Indians, and non-Hispanic whites, 1958-1987. J. Natl. Cancer Inst., 85: 1670-1678, 1993.
3. Polednak, A. P. Lung cancer rates in the Hispanic population of Connecticut, 1980-1988. Public Health Rep., 108: 471-476, 1993.
4. Ries, L. A. G., Hankey, B. F., Miller, B. A., Hartman, A., and Edwards, B. K. Cancer Statistics Review: 1973-1988. NIH Publ. No. 91-2789. Bethesda, MD: National Cancer Institute, 1991 .
5. Gorey, K. M., and Vena, J. E. Cancer differentials among U. S. blacks and whites: quantitative estimates of socioeconomic-related risks. J. Natl. Med. Assoc., 86: 209-215, 1994.
6. Centers for Disease Control. Cigarette smoking among adults: United States, 1990. Morb. Mortal. Wkly. Rep., 41: 354-362, 1992.
7. United States Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General. Department of Health and Human Sen ices Publ. No. (CDC) 89-8411. Washington DC: United States Government Printing Office, 1989.
8. Palinkas, L. A., Pierce, J., Rosbrook, B. P., Pickwell, S., Johnson, M., and Bal, D. G. Cigarette smoking behavior and beliefs of Hispanics in California. Am. J. Prev. Med., 9: 331-337, 1993.
9. Wu, X., Delclos, G. L., Annegers, J. F., Bondy, M. L., Honn, S. E., Henry, B., Hsu, T. C., and Spitz, M. R. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiology, Biomarkers & Prev., 4: 583-588, 1995.
10. Jin, X., Wu, X., Roth, J. A., Amos, C. I., King, T. M., Branch, C., Honn, S. E., and Spitz, M. R. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis (Lend.), 16: 2205-2208, 1995.
11. Daly, A. K., Cholerton, S., Armstrong, M., and Idle, J. R. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ. Health Perspect., 102 (Suppl. 9): 55-61, 1994.
12. Bell, D. A., Thompson, C. L., Taylor, J., Miller, C. R., Perera, F., Hsieh, L. L., and Lucier, G. W. Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase μ. Environ. Health Perspect., 98: 113-117, 1992.
13. Evans, W. E., Relling, M. V., Rahman, A., McLeod, H. L., Scott, E. P., and Lin, J. S. Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans. J. Clin. Invest., 91: 2150-2154, 1993.
14. Nelson, H. H., Wiencke, J. K., Christiani, D. C., Chens, T. J., Zuo, Z. F. Schwartz, B. S., Lee, B. K., Spitz, M. R., Wang, M., Xu, X., and Kelsey, K. T. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase θ. Carcinogenesis (Lond.), 16: 1243-1245, 1995.
15. Kawajiri, K., Watanabe, J., Eguchi, H., and Hayashi, S. Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility. Pharmacogenetics, 5: S70-S73, 1995.
16. Me Williams, J. E., Sanderson, B. J., Harris, E. L., Richert-Boe, K. E., and Henner, W. D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol., Biomarkers & Prev., 4: 589-594, 1995.
17. Li, R., Bianchet, M. A., Talalay, P., and Amzel, L. M. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc. Natl. Acad. Sci. USA, 92: 8846-8850, 1995.